# Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome

> **NCT06137157** · PHASE1 · RECRUITING · sponsor: **Azitra Inc.** · enrollment: 12 (estimated)

## Conditions studied

- Netherton Syndrome

## Interventions

- **DRUG:** ATR12-351

## Key facts

- **NCT ID:** NCT06137157
- **Lead sponsor:** Azitra Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-19
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06137157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06137157, "Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06137157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*